期刊文献+

乏氧环境下益气养精方对肺癌细胞apelin分子表达的影响 被引量:3

Effects of Enhancing Qi and Nourishing Essence Formula on the Expression of Apelin in Lung Adenocarcinoma Cells under Hypoxic Condition
下载PDF
导出
摘要 目的观察益气养精方对乏氧微环境下肺癌细胞中具有促进细胞增殖侵袭及血管形成的apelin/APJ信号通路的影响。方法 CoCl2加入培养基模拟乏氧微环境,实验分组为乏氧组、常氧益气养精方组、乏氧益气养精方组及空白对照组,分别作用于人肺癌细胞株A549和H1975。采用CCK-8法和Transwell实验观察各组细胞的增殖、侵袭能力,RT-qPCR、Western Blot方法观察apelin/APJ信号通路相关因子VEGF、HIF-1α、PI3K等在各组干预细胞中的mRNA和蛋白表达。结果 CCK-8实验测得,缺氧环境能促进肺癌细胞增殖,益气养精方作用于A549、H1975的IC50分别为为1 mg·mL^-1和0.5 mg·mL^-1,且在常氧和缺氧微环境中均能抑制肺癌细胞增殖。Transwell实验结果显示,益气养精方组下室面细胞数量明显少于对照组(P <0.01),乏氧微环境中下室面细胞数明显多于对照组(P <0.01),加入益气养精方后亦可见减少。RT-qPCR结果显示,益气养精方在乏氧微环境中能不同程度下调血管生成相关因子HIF-1α、VEGF、APJ及Apelin的表达(P <0.05)。Western Blot检测发现,益气养精方在乏氧环境中能使相关因子(VEGF、PI3K、APJ)的表达量明显下调,具有统计学意义。结论益气养精方在乏氧微环境中能抑制肺癌细胞的增殖和侵袭,同时能通过Apelin/APJ通路对血管生成相关因子VEGF、HIF-1a、PI3K等起到一定的下调作用。 Objective To observe the effect of enhancing qi and nourishing essence formula on cell proliferation, invasion and angiogenesis of lung adenocarcinoma cells under hypoxic condition via Apelin/APJ signaling pathway. Methods CoCl2 working fluid was used to produce hypoxic microenvironment. Human lung cancer cell lines A549 and H1975 were treated with hypoxic, enhancing qi and nourishing essence formula, hypoxia enhancing qi and nourishing essence formula and control group respectively. The effect of each group on cell proliferation and invasion was observed by CCK-8 assay and Transwell assay. The expression of angiogenesis-related factors, such as VEGF, HIF-1α and PI3 K, was observed by RT-qPCR experiment and Western Blotting assay. Results CCK-8 assay showed that hypoxic environment could promote the proliferation of lung cancer cells. The IC50 of Enhance Qi Nourish Jing formula was determined to be about 1 mg/ml for A549 cells, and 0.5 mg/ml for H1975 cells. The formula can inhibit the proliferation of lung cancer cells in no matter normal or hypoxic microenvironment. Transwell results showed that the number of cells in the lower chamber of the enhancing qi and nourishing essence formula group was significantly lower than that in the control group(P < 0.01), and the number of cells in the hypoxic microenvironment was significantly higher than that in the control group(P < 0.01), the reduction can also been observed after treated with the formula. The results of RT-qPCR showed that enhancing qi and nourishing essence formula could down-regulate the expression of angiogenesis-related factors HIF-1α, VEGF, APJ and Apelin in the hypoxic microenvironment(P < 0.05). Western Blot analysis showed that enhancing qi and nourishing essence formula can significantly down-regulate the expression of related factors(VEGF,PI3 K, APJ) in a hypoxic environment, with statistically significant. Conclusion Enhancing qi and nourishing essence formula can inhibit the proliferation and invasion of lung cancer cells in hypoxic microenvironment. At the same time, it can down-regulate the angiogenesis-related factors VEGF, HIF-1 a and PI3 K through Apelin/APJ pathway.
作者 卢文峰 杨茜雯 董昀 崔清 蔡霄月 汪宇涵 张铭 邓海滨 徐振晔 Lu Wenfeng;Yang Xiwen;Dong Yun;Cui Qing;Cai Xiaoyue;Wang Yuhan;Zhang Ming;Deng Haibin;Xu Zhenye(Department of Integrated TCM and Western Medicine,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai 200030,China;Department of Oncology,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China)
出处 《世界科学技术-中医药现代化》 CSCD 北大核心 2019年第11期2532-2539,共8页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 国家自然科学基金委员会面上项目(81573893):从apelin/APJ系统探讨益气养精方抑制肺癌血管生成及侵袭转移的机制,负责人:张铭 上海市教育委员会科研创新计划重大项目(2017-01-07-00-10-E00064):源于精气理论的肺岩宁方抗肿瘤生长与转移作用机制的研究,负责人:邓海滨。
关键词 中医药 非小细胞肺癌 APELIN/APJ 血管生成 Traditional Chinese medicine Non-small lung cancer Apelin/APJ Angiogenesis
  • 相关文献

参考文献9

二级参考文献59

  • 1周卫东,徐振晔,王中奇,朱晏伟,王立芳.抗瘤增效方对NSCLC化疗患者免疫功能及血清VEGF、CYFRA21-1的影响[J].上海中医药杂志,2005,39(3):6-8. 被引量:16
  • 2王中奇,徐振晔,周卫东,邓海滨,张铭,张晖.中西医结合规范化治疗非小细胞肺癌的临床研究[J].中医药通报,2006,5(3):39-43. 被引量:12
  • 3王中奇,徐振晔,邓海滨,张铭.肺岩宁方抗C57小鼠Lewis肿瘤血管生成的实验研究[J].上海中医药杂志,2006,40(7):66-67. 被引量:27
  • 4郑展,徐振晔.肿瘤干细胞研究进展与扶助肾中精气抗癌[J].中国中西医结合杂志,2007,27(1):89-92. 被引量:5
  • 5吴阶平 裘法祖.黄家驷外科学(第4版)[M].北京:人民卫生出版社,1986.444.
  • 6Shepherd FA, Rodrigues Pereira JR, Ciuleanu T, et al Erlotinib in previously treated non-small-cell lung cancer [J] .N Engl J Med, 2005, 353 (2) : 123-132.
  • 7Gatzemeier U, Pluzanska A, Szczesna A, et al. Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial [J]. J Clin Oncol, 2007, 25 (12): 1545-1552.
  • 8Herbst RS, Prager D, Hermann R, et al. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non- small-cell lung cancer[J]. J Clin Oncol, 2005, 23 (25) : 5892-5899.
  • 9Rosell R, Robinet G, Szczesna A, et al. Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR- expressing advanced non-small-cell lung cancer[J]. Ann Oncol, 2008, 19(2): 362-369.
  • 10Pirker R, Szczesna A, yon Pawel J, et al. FLEX: a randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients withadvanced non-small cell lung cancer (NSCLC) [J]. J Clin Oncol, 2008, 26 (May 20 Suppl; abstr 3).

共引文献203

同被引文献69

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部